Tcf-4 and Osteopontin in Breast Cancer Progression
Author Information
Author(s): Ravindranath A, Yuen H-F, Chan K-K, Grills C, Fennell D A, Lappin T R, El-Tanani M
Primary Institution: Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast
Hypothesis
Tcf-4 regulates osteopontin (OPN) in human breast cancer and its expression affects cancer progression.
Conclusion
Tcf-4 can act as a repressor or activator of breast cancer progression by regulating OPN expression in a Wnt-dependent manner.
Supporting Evidence
- Tcf-4 enhances cell invasion in breast cancer cells by activating OPN expression.
- High levels of OPN and Tcf-4 mRNA expression are significantly associated with survival in breast cancer patients.
- Tcf-4's role in breast cancer can vary depending on the presence of Wnt signaling.
Takeaway
This study shows that a protein called Tcf-4 can help cancer cells grow and spread by controlling another protein called osteopontin, depending on certain signals in the body.
Methodology
The study involved cell culture experiments, mRNA expression analysis, and survival data correlation from breast cancer patient datasets.
Potential Biases
Potential bias in patient selection and data interpretation from multiple datasets.
Limitations
The study primarily relies on in vitro data and may not fully represent in vivo conditions.
Participant Demographics
The study analyzed data from 455 breast cancer patients across three datasets.
Statistical Information
P-Value
0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website